Advertisement

Expression of the fgl2 and Its Protein Product (Prothrombinase) in Tissues During Murine Hepatitis Virus Strain-3 (MHV-3) Infection

  • J. W. Ding
  • Q. Ning
  • M. F. Liu
  • A. Lai
  • K. Peltekian
  • L. Fung
  • C. Holloway
  • H. Yeger
  • M. J. Phillips
  • G. A. Levy
Chapter
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 440)

Abstract

Murine Hepatitis Virus Strain 3 (MHV-3) produces fulminant hepatitis with 80–90% mortality in Balb/cJ mice. Previous studies in our laboratory have shown that peritoneal macrophages from MHV-3 infected mice produce a procoagulant (PCA) which has the ability to cleave prothrombin to thrombin (prothrombinase) encoded by the gene fgl2 located on chromosome 5. PCA accounts for sinusoidal thrombosis and hepatic necrosis and the necrosis and mortality can be prevented by treatment of animals with a monoclonal antibody to PCA. These present studies were designed to examine the expression of this gene (mRNA by Northern analysis and in situ hybridization) and the gene product PCA (immunochemistry) in tissues recovered from MHV-3 infected Balb/cJ mice in an attempt to explain the liver specific nature of MHV-3 disease. Fgl2 gene expression was detected as early as 8 hours after MHV-3 infection which persisted to 48 hours in the liver, spleen and lungs whereas no gene expression was seen in the brain or kidneys despite the fact that equivalent viral titers were detected in all tissues at all times. In the liver, fgl2 gene expression was confined to endothelial and Kupffer cells with no expression in hepatocytes. Immunochemistry localized the PCA protein to Kupffer cells and endothelial cells and necrotic foci within the liver. No PCA protein was detected by immunochemistry in any other tissues at any time during the course of MHV-3 infection.

These results explain the liver specific nature (fulminant hepatitis) of MHV-3 infection and provides further evidence for the role of PCA in the pathogenesis of fulminant hepatitis. MHV-3 induces selective transcription of the genefgl2 and only hepatic reticuloendothelial cells produce functional protein (PCA) which is known to account for fulminant hepatic failure produced by MHV-3.

Keywords

Kupffer Cell Fulminant Hepatitis Fibrin Deposition Hepatic Necrosis Hepatic Sinusoid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Houtman, J. J., and Fleming, J. O., 1996, Pathogenesis of mouse hepatitis virus-induced demyelination, J. Neurovirol. 2:361–270.PubMedCrossRefGoogle Scholar
  2. Janousek, J., Strmen, E., and Gervais, F., 1993, Purification of murine Kupffer cells by centrifugal elutriation, J. Immunol. Methods 164:109–117.PubMedCrossRefGoogle Scholar
  3. Levy, G. A., Leibowitz, J. L., and Edgington, T. S., 1981, The induction of monocyte procoagulant activity by murine hepatitis virus MHV-3 parallels disease susceptibility in mice, J. Exp. Med. 154:1150–1163.PubMedCrossRefGoogle Scholar
  4. Levy, G. A., Helin, H., and Edgington, T. S., 1984, The pathobiology of viral hepatitis and immunologic activation of the coagulation protease network, Sem. Liver Dis. 4:59–68.CrossRefGoogle Scholar
  5. Li, C., Fung, L. S., Crow, A., Myers-Mason, N., Phillips, M. J., Leibowitz, J. L., Cole, E., Ottaway, C. A., and Levy, G. A., 1992, Monoclonal antiprothrombinase (3D4.3) prevents mortality from murine hepatitis virus (MHV-3) infection, J. Exp. Med. 176:689–697.PubMedCrossRefGoogle Scholar
  6. Mori, W., Shiga, J., and Irie, H., 1986, Schwartzman reaction as a pathogenetic mechanism in fulminant hepatitis, Sem. Liver Dis. 6:267–269.CrossRefGoogle Scholar
  7. Mori, W., and Naoto, A., 1981, Acute hepatic cell necrosis experimentally produced by viral agents in rabbits, Am. J. Pathol. 103:31–35.PubMedGoogle Scholar
  8. Parr, R. L., Fung, L., Reneker, J., Myers-Mason, N., Leibowitz, J. L., and Levy, G.A., 1995, Association of mouse fibrinogen-like protein with murine hepatitis virus-induced prothrombinase activity, J. Virol. 69:5033–5038.PubMedGoogle Scholar
  9. Piazza, M. (ed.) 1969, Experimental viral hepatitis, Charles C. Thomas, Springfield, Illinois.Google Scholar
  10. Pope, M., Rotstein, O., Cole, E., Sinclair, S., Parr, R., Cruz, B., Fingerote, R., Chung, S., Gorczynski, R., Fung, L., Leibowitz, J., Rao, Y. S., and Levy, G. A., 1995, Pattern of disease after murine hepatitis virus strain 3 infection correlates with macrophage activation and not viral replication, J. Virol. 69:5252–5260.PubMedGoogle Scholar
  11. Portmann, B., Talbot, I. C., Day, D. W., Davidson, A. R., Murray-Lyon, I. M., and Williams, R, 1975, Histopathological changes in the liver following a paracetamol overdose: correlation with clinical and biochemical parameters, J. Pathol. 117:169–181.PubMedCrossRefGoogle Scholar
  12. Qureshi, S. T., Clermont, S., Leibowitz, J. L., Levy, G. A. and Malo, D., 1995, Mouse hepatitis virus-3 induced prothrombinase (Fgl2) maps to proximal chromosome 5, Genomics 29:307–309.PubMedCrossRefGoogle Scholar
  13. Ribaudo, R., Gilman, M., Kingston, R. E., Chomczynski, P., and Sacchi, N., 1991, Single-step RNA isolation from cultured cells or tissues, in: Current Protocols in immunology (Supplement 3) (J. E. Coligan, A. M. Kruisbeek, D.H. Margulies, E.M. Shevach and W. Strober, eds.), John Wiley & Sons, Inc., pp. 10.11.7–10.11.14Google Scholar
  14. Seglen, P. O., 1973, Preparation of rat liver cells, Exptl. Cell Res. 82:391–398.PubMedCrossRefGoogle Scholar
  15. Wang, D., Yeger, H., and Cutz, E., 1996, Expression of gastrin releasing peptide receptor gene in developing lung, Am. J. Repir. Cell Mol. Biol. 14:409–416.Google Scholar
  16. Yuwaraj, S., Cattral, M., Pope, M. and Levy, G. A. 1996, Murine hepatitis virus: Molecular biology and pathogenesis, Viral Hepatitis 2:125–142.Google Scholar
  17. Zimmerman, H. J., and Ishak, K. G, 1982, Valproate-induced hepatic injury: analysis of 23 fatal case, Hepatology 2:591–597.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • J. W. Ding
    • 1
  • Q. Ning
    • 1
  • M. F. Liu
    • 1
  • A. Lai
    • 1
  • K. Peltekian
    • 2
  • L. Fung
    • 1
  • C. Holloway
    • 3
  • H. Yeger
    • 4
  • M. J. Phillips
    • 4
  • G. A. Levy
    • 1
  1. 1.Department of Multi Organ Transplantation Program and Medicine Toronto HospitalUniversity of TorontoTorontoCanada
  2. 2.Department of MedicineDalhousie UniversityHalifaxCanada
  3. 3.Department of Surgery, Women’s College HospitalUniversity of TorontoTorontoCanada
  4. 4.Department of Pathology, The Hospital for Sick ChildrenUniversity of TorontoTorontoCanada

Personalised recommendations